市场调查报告书
商品编码
1215803
胃酸分泌药物市场 2022-2028Gastric Antisecretory Drug Market 2022-2028 |
在预测期内,全球胃酸抑製剂市场预计将以 3.8% 的复合年增长率增长。 世界主要国家因不健康生活方式的转变,导致胃食管反流病(GERD)、胃酸过多、消化性溃疡等疾病负担日益加重,推动抗胃分泌药需求急剧增加。 此外,专注于研发和市场扩张活动以将高度可靠的新配方引入市场的主要公司的存在也是市场增长的推动力。
全球酸抑製剂市场根据类型、应用和最终用户进行细分。 按类型划分,市场分为 H2 受体拮抗剂、胃质子泵抑製剂等。 胃质子泵抑製剂部分有望见证市场增长的潜在份额。 GERD 的日益流行和对新药物输送系统的日益接受是推动该领域增长的一些关键因素。 根据应用,市场分为消化不良、消化性溃疡、胃食管反流等。 根据最终用户,市场分为医院、诊所等。
按地区划分,胃酸抑製剂市场分为北美、欧洲、亚太地区和世界其他地区。 由于对胃肠道疾病和疾病的认识提高以及医疗保健基础设施的改善,预计北美和欧洲将占据主要市场份额。 这些地区的生物製药公司正在大力投资研发活动,大量产品处于临床审批的不同阶段,并有可能在预测期内实现商业化。 此外,由于患有胃病的老年人越来越多以及对联合疗法的偏好,对抑酸药物的需求增加,预计亚太地区抑酸剂市场将增长最快。
Title:Global Gastric Antisecretory Drug Market Size, Share, and Trends Analysis Report, By Type (H2-receptor Antagonists, Gastric Proton Pump Inhibitors, and Others), By Application (Dyspepsia, Peptic Ulcer, Gastroesophageal Reflux, and Others), By End-User (Hospitals, Clinics, and Others), Forecast Period (2022 to 2028).
The global gastric antisecretory drug market is anticipated to grow at a CAGR of 3.8% during the forecast period. The rising burden of gastroesophageal reflux disease (GERD), gastroesophageal reflux, peptic ulcer, and other diseases in the major economies globally due to people's shift toward unhealthy lifestyles is the key factor surged the demand for gastric antisecretory drugs. The market growth is also driven by the presence of major market players who are focused on R&D and market expansion activities to bring new and reliable formulations to the market.
The global gastric antisecretory drug market is segmented based on type, application, and end-user. Based on type, the market is segmented into H2-receptor antagonists, gastric proton pump inhibitors, and others. The gastric proton pump inhibitors segment is likely to witness a potential share in the growth of the market. The increasing prevalence of GERD and the rising acceptance of novel drug delivery systems are some crucial factors that have boosted the segment growth. Based on application, the market is segmented into dyspepsia, peptic ulcer, gastroesophageal reflux, and others. Based on end-user, the market is segmented into hospitals, clinics, and others.
Geographically, the gastric antisecretory drug market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America and Europe are expected to hold a major share of the market owing to the surge in awareness about gastrointestinal disorders/diseases and improvement in health care infrastructure. Biopharmaceutical companies in these regions have made significant investments in R&D activities, and a large number of pipeline products are at different stages of clinical approval and are likely to commercialize during the forecast period. Besides, the gastric antisecretory drug market in the Asia-Pacific region is expected to be the fastest growing owing to the increasing geriatric population affected with gastric problems that have increased the demand for gastric antisecretory drugs and surging preference for combination therapies.
The major players in the global gastric antisecretory drug market include Pfizer Inc., Sanofi-Aventis US LLC, and Takeda Pharmaceutical Co. Ltd., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and new product launches, to stay competitive in the market.
Research Methodology
The market study of the global gastric antisecretory drug is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include:
The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
The Report Covers: